Stay updated with breaking news from Sera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sera Prognostics (NASDAQ:SERA – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare Sera Prognostics to related companies based on the strength of its dividends, institutional ownership, analyst recommendations, earnings, profitability, valuation and risk. Analyst Ratings This is a summary […]
Sera Prognostics (NASDAQ:SERA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, Zacks.com reports. According to Zacks, “Sera Prognostics Inc. is a women’s health diagnostics company. It focused on improving maternal and neonatal health by providing […]
Voices Festival Productions with the Arts Club of Washington joins a worldwide project to bear witness through theater to the horrors of Putin’s war.
Sera Prognostics (NASDAQ:SERA – Get Rating) and Viridian Therapeutics (NASDAQ:VRDN – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Earnings & Valuation This table compares Sera Prognostics and […]
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 179,000 shares, an increase of 62.7% from the March 15th total of 110,000 shares. Based on an average daily trading volume, of 55,000 shares, the days-to-cover ratio […]